In the current study, we investigated the clinical significance of tumor expressions of HIF1A, VEGFA, CA9, and SLC2A1 assessed by IHC and markers of systemic inflammation (NLR and CRP) in pediatric patients with MPNST. The gene discussed is HIF1A; the disease is malignant peripheral nerve sheath tumor.